Cargando…
Broad-spectrum humanized monoclonal neutralizing antibody against SARS-CoV-2 variants, including the Omicron variant
INTRODUCTION: Therapeutic monoclonal antibodies (mAbs) against the SARS-CoV-2 spike protein have been shown to improve the outcome of severe COVID-19 patients in clinical trials. However, novel variants with spike protein mutations can render many currently available mAbs ineffective. METHODS: We pr...
Autores principales: | Wen, Kun, Cai, Jian-Piao, Fan, Xiaodi, Zhang, Xiaojuan, Luo, Cuiting, Tang, Kai-Ming, Shuai, Huiping, Chen, Lin-Lei, Zhang, Ricky Ruiqi, Situ, Jianwen, Tsoi, Hoi-Wah, Wang, Kun, Chan, Jasper Fuk-Woo, Yuan, Shuofeng, Yuen, Kwok-Yung, Zhou, Hongwei, To, Kelvin Kai-Wang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461085/ https://www.ncbi.nlm.nih.gov/pubmed/37645378 http://dx.doi.org/10.3389/fcimb.2023.1213806 |
Ejemplares similares
-
Fusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2, including Delta and Omicron variants
por: Zhao, Hanjun, et al.
Publicado: (2022) -
A trifunctional peptide broadly inhibits SARS-CoV-2 Delta and Omicron variants in hamsters
por: Zhao, Hanjun, et al.
Publicado: (2022) -
Intranasal Boosting with Spike Fc-RBD of Wild-Type SARS-CoV-2 Induces Neutralizing Antibodies against Omicron Subvariants and Reduces Viral Load in the Nasal Turbinate of Mice
por: Cai, Jian-Piao, et al.
Publicado: (2023) -
Vaccine‐breakthrough infection by the SARS‐CoV‐2 omicron variant elicits broadly cross‐reactive immune responses
por: Zhou, Runhong, et al.
Publicado: (2022) -
Peptidic defective interfering gene nanoparticles against Omicron, Delta SARS-CoV-2 variants and influenza A virus in vivo
por: Zhao, Hanjun, et al.
Publicado: (2022)